National Healthcare Agreement: PI 02–Incidence of selected cancers, 2022
Indicator Attributes
Identifying and definitional attributes | |
Metadata item type: | Indicator |
---|---|
Indicator type: | Progress measure |
Short name: | PI 02–Incidence of selected cancers, 2022 |
METEOR identifier: | 740892 |
Registration status: | Health, Standard 24/09/2021 |
Description: | Incidence of selected cancers of public health importance. |
Indicator set: | National Healthcare Agreement (2022) Health, Standard 24/09/2021 |
Outcome area: | Prevention Health, Standard 07/07/2010 |
Collection and usage attributes | |
Computation description: | Rates directly age-standardised to the 2001 Australian Standard Population. Analyses by state and territory, remoteness and Socio-Economic Indexes for Areas (SEIFA) Index of Relative Socio-Economic Disadvantage (IRSD) are based on the Statistical Area Level 2 (SA2) of the person at the time of their diagnosis. Rates that are considered unstable and should be interpreted with caution will be noted. Rates that are considered very unstable will not be published. Presented as:
|
---|---|
Computation: | 100,000 × (Numerator ÷ Denominator) Calculated separately for each type of cancer. |
Numerator: | For melanoma, bowel and lung cancer: Number of new cases in the reported year. For cervical and breast cancer in females: Number of new cases in females in the reported year. |
Numerator data elements: | |
Denominator: | For melanoma, bowel and lung cancer: Total population. For cervical and breast cancer in females: Total female population. |
Denominator data elements: | |
Disaggregation: | 2017, 2018, 2019 — State and territory, by:
2017, 2018, 2019 — Nationally, by:
Cancer types in these disaggregations comprise: bowel cancer (ICD-10 2016 version codes C18–C20), lung cancer (C33–C34), melanoma of the skin (C43), female breast cancer (C50) and cervical cancer (C53). Disaggregations by remoteness are based on the Statistical Area Level 2 (SA2) of the patient's usual residence at the time of diagnosis, using the 2016 ASGS. The 2019 tables only include data from Victoria and South Australia. Some disaggregation may result in numbers too small for publication. |
Disaggregation data elements: | |
Comments: | Most recent data available for 2022 National Healthcare Agreement performance reporting: 2019 for Victoria and South Australia; 2018 for New South Wales, Queensland, Western Australia, Tasmania and the Australian Capital Territory; 2017 for the Northern Territory. Incidence rates of cancers in jurisdictions with smaller populations can fluctuate considerably from year to year. Comparisons across time and between jurisdictions should be made with caution. New South Wales data for 2018 are partially incomplete with respect to death-certificate-only cases. Therefore, the counts and rates are slight under-estimates. Further details on cancer incidence in Indigenous Australians are available from the Aboriginal and Torres Strait Islander Health Performance Framework (measure 1.08: Cancer). |
Representational attributes | |
Representation class: | Rate |
Data type: | Real |
Unit of measure: | Episode |
Format: | N[NN].N |
Indicator conceptual framework | |
Framework and dimensions: | Health conditions |
Data source attributes | |
Data sources: | |
Accountability attributes | |
Reporting requirements: | National Healthcare Agreement |
Organisation responsible for providing data: | Australian Institute of Health and Welfare |
Further data development / collection required: | Specification: Final, the measure meets the intention of the indicator. |
Source and reference attributes | |
Reference documents: | Australian Institute of Health and Welfare (AIHW) 2020. Aboriginal and Torres Strait Islander Health Performance Framework. Canberra: AIHW. Viewed 19 February 2021, https://indigenoushpf.gov.au/ |
Relational attributes | |
Related metadata references: | Supersedes National Healthcare Agreement: PI 02–Incidence of selected cancers, 2021 Health, Standard 16/09/2020 See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2020 Health, Standard 01/12/2020 See also Australian Health Performance Framework: PI 2.1.5–Survival of people diagnosed with cancer, 2021 Health, Qualified 31/05/2023 See also Australian Health Performance Framework: PI 3.1.2–Incidence of selected cancers, 2020 Health, Standard 13/10/2021 See also National Healthcare Agreement: PI 24–Survival of people diagnosed with notifiable cancers, 2022 Health, Standard 24/09/2021 |